11/18/2025
If you’re wondering where the latest high-tech innovations in laparoscopic surgery are coming from, take a look at LivsMed.
LivsMed and Sovato recently completed an early-feasibility wet-lab study—spanning more than 2,000 miles—using STARK, the world’s newest telesurgery-native robot. Visitors can learn more at the 16th Clinical Robotic Surgery Association (CRSA) World Congress in Huntington Beach, as we wrap up our November High-Tech MedTech Roadshow.
So far, the Roadshow has made stops at the 50th Annual Korean-American Medical Association (K**A) Scientific Convention in Washington, D.C., the AAGL25 Global Conference in Vancouver, and the ASMBS Weekend Meeting in Louisville, KY. Attendees have experienced the ArtiSential™ line—now featuring more than 50 fully articulating instruments and end effectors; the ArtiSential 5 series, the first 5mm articulating laparoscopic line offering enhanced flexibility and ease of use; the ArtiSential Clip Applier, the only 90° double-jointed articulating clip applier; and ArtiSeal™, the only 90° double-jointed articulating vessel sealer.
If you can’t see us on the road, email infoUSA@LivsMed.com to schedule a meeting with your local LivsMed representative and experience LivsMed’s solutions at work in your hospital or ASC.
STARK™ is not approved for use and not for sale.